FEVRX Mutual Fund

NAV$26.02

Fund Essentials - as of Jan 31, 2026

Net Assets
$67M
Expense Ratio
0.83%
Dividend Yield (Current)
9.41%
Holdings
83
Inception Date
Mar 1, 2017
Fund Family
First Eagle Investments
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+0.84%
1 Year+14.19%
3 Year+14.78%
5 Year+10.29%

Asset Allocation

Stocks: 78.60%
Bonds: 7.74%
Cash: 0.64%
Other: 13.02%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
-Fx Forwards13.01%
GOOGAlphabet Inc series C4.06%
METAMeta Platforms, Inc.3.81%
BDXBecton Dickinson And Co.3.73%
HCAHca Holdings Inc3.50%
Top 10 Concentration: 41.14%Report Date: Jan 31, 2026
Download all 83 holdings for FEVRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
9.41%
Frequency
Annually
Latest Distribution
$1.94
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how FEVRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

FEVRX Mutual Fund Overview

FEVRX Mutual Fund (First Eagle US Value Fund Class R6) is managed by First Eagle Investments with $67.1M in net assets. FEVRX expense ratio is 0.83%, holding 83 positions across sectors including Other, Communication Services, Unknown. Inception date: 2017-03-01.

FEVRX performance shows a YTD return of 0.84%. The 1-year return is 14.19% and the 5-year return is 10.29%. FEVRX dividend yield stands at 9.41%, paid annually.

FEVRX top holdings include Fx Forwards (13.0%), Alphabet Inc series C (4.1%), Meta Platforms, Inc. (3.8%), Becton Dickinson And Co. (3.7%), Hca Holdings Inc (3.5%). View all FEVRX holdings, sector breakdown, or dividend history.

FEVRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FEVRX alternatives are available via the screener, along with tax-loss harvesting opportunities.